Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?

Helicobacter pylori (H. pylori) antimicrobial resistance is an urgent, global issue. In 2017, the World Health Organization designated clarithromycin-resistant H. pylori as a high priority bacterium for antibiotic research and development. In addition to clarithromycin, resistance to metronidazole a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Sho, Esaki, Mitsuru, Kusano, Chika, Ikehara, Hisatomo, Gotoda, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487377/
https://www.ncbi.nlm.nih.gov/pubmed/31086459
http://dx.doi.org/10.3748/wjg.v25.i16.1907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487377/
https://www.ncbi.nlm.nih.gov/pubmed/31086459
http://dx.doi.org/10.3748/wjg.v25.i16.1907

Ejemplares similares